David Hussong, Ph.D.

Dr. David Hussong is the Chief Technical Officer at Eagle.  He also served as the chair of the USP Microbiology Expert Committee for the 2015– 2020 cycle.  He has been active with USP for over 20-years in various roles.  David retired after a 30-year career at the Food and Drug Administration (FDA), where he had served in many microbiology positions, culminating as the Associate Director of New Drug Microbiology at CDER.  After retirement from FDA, he began consulting for the regulated industry.  David previously also was a research microbiologist at the US Department of Agriculture and the US Naval Medical Research Institute.

David earned his Ph.D. in microbiology at the University of Maryland, where he studied environmental microbiology and developed detection methods for Legionella spp.  He has about 50 publications covering various topics such as microbial ecology, recovery of Salmonella spp., immunologic detection of Mycobacteria, sterilizing filtration, modern microbiology methods, survival and recovery of Burkholderia, advanced aseptic filling and endotoxins testing.

 

 

Dr. Hussong smiles while wearing an Eagle lab coat.

Publications

Publications by Dr. David Hussong
  1. Hussong, D. 2017. Current, Ideal and Anticipated Regulations for Sterile Drug Products. In T. Sandle and E.C. Tidswell (ed.), Davis Healthcare International Publishing, LLC, River Grove, IL. (in press)
  2. Jung, J.Y., Y. Ahn, O. Kweon, J.J. LiPuma, D. Hussong, B.S. Marasa, and C.E. Cerniglia. 2017. Improved High-Quality Draft Genome Sequence and Annotation of Burkholderia contaminans LMG 23361. Genome Announcements 5(16): Online at http://genomea.asm.org/content/5/16/e00245-17.full
  3. Stappen, M., and D. Hussong. 2017. The LAL Assay for Pyrogen Testing of Parenteral Products: Evolution & Challenges. Online at https://www.pharmaceuticalonline.com/doc/the-lal-assay-for-pyrogen-testing-of-parenteral-products-evolution-challenges-0001
  4. McCullough, K.Z., R.S. Tirumalai, D. Hussong, J. Akers, D.E. Guilfoyle, R. Mello, and D. Singer. 2016. Endotoxins standards and their role in recovery studies: The path forward. BioPharm Asia. Online at https://biopharma-asia.com/magazine-articles/endotoxins-standards-and-their-role-in-recovery-studies-the-path-forward/
  5. Ahn, Y., J. M. Kim, O. Kweon, S-J. Kim, R.C. Jones, K. Woodling, G.G. da Costa, J.J. LiPuma, D. Hussong and C.E. Cerniglia. 2016. Intrinsic resistance of Burkholderia cepacia complex to benzalkonium chloride. mBio 7(6): 1 – 11. Online at http://mbio.asm.org/content/7/6/e01716-16.full.pdf+html
  6. Tirumalai, R.S., D. Hussong, J. Akers, and K. McCullough. 2016. USP Perspectives on LAL Assay Interference and NOE Standard. PDA Letter 52(10): 22-16.
  7. Agalloco, J., J.L. Quick, L. Mestrandrea, and D. Hussong. 2015. Closed System Filling Technology: A New Paradigm. PDA Letter Letter (10): 26 – 28.
  8. Kim, J. M., Y.A. Ahn, J. J. LiPuma, D. Hussong, and C. E. Cerniglia. 2015. Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride. Journal of Industrial Microbiology & Biotechnology 42(6): 905 – 913.
  9. Yu, L.X., J. Baker, S. C. Berlam, A. Boam, E. J. Brandreth, L. Buhse, T. Cosgrove, D. Doleski, L. Ensor, J. Famulare, M. Ganapathy, G. Grampp, D. Hussong, R. Iser, G. Johnston, F. Kesisoglou, M. Khan, S. Kozlowski, E. Lacana, S. L. Lee, S. Miller, S. Pope Miksinski, C. M. V. Moore, T. Mullin, G. K. Raju, A. Raw, S. Rosencrance, M. Rosolowsky, P. Stinavage, H. Thomas, R. Wesdyk, J. Windisch, and S. Vaithiyalingam. 2015. Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference. The AAPS Journal 17(4): 1011-1018. https://www.ncbi.nlm.nih.gov/pubmed/25840884
  10. Ahn, Y., J. M. Kim, H. Ahn, Y.‑ Lee, J. J. LiPuma, D. Hussong, and C.E. Cerniglia. 2014. Evaluation of liquid and solid culture media for the recovery and enrichment of Burkholderia cenocepacia from distilled water. Journal of Industrial Microbiology and Biotechnology 41:1109–1118.
  11. Kaushal, S., B. Gervais, S. Lute, A. Eroraha, P. Faustino, K. Brorson, and D. Hussong. 2013. Evidence for grow-through penetration of 0.2-um-pore-size filters by Serratia marcescens and Brevundimonas diminuta. Journal of Industrial Microbiology and Biotechnology 40 (3): 327-334.
  12. Torbeck, L., D. Raccasi, D.E. Guilfoyle, R.L. Friedman, and D. Hussong. 2011. Burkholderia cepacia: This decision is overdue. PDA Journal of Science and Technology 65(5): 535 – 543.
  13. Hussong, D. 2010. The Evolution of Advanced Aseptic Processing for Pharmaceutical Manufacturing: Perspectives of a Regulatory Scientist, p. 360 – 368. In J. Agalloco and J. Akers (eds.), Advanced Aseptic Processing. Informa Healthcare, London.
  14. Lee, A., J. McVey, P. Faustino, S. Lute, N. Sweeney, V. Pawar, M. Khan, K. Brorson, and D. Hussong. 2010. Use of Hydrogenophaga pseudoflava Penetration to Quantitatively Assess the Impact of Filtration Parameters for 0.2-Micrometer-Pore-Size Filters. Applied and Environmental Microbiology 76 (3): 695 – 700.
  15. Hussong, D. 2009. Water Activity and Pharmaceutical Manufacturing; A Regulatory Microbiology Perspective. In A.M. Cundell and A.J. Fontana (ed.), Water Activity Applications in the Pharmaceutical Industry. Davis Healthcare International, River Grove, IL.
  16. Langille, S., L. Ensor and D. Hussong. 2009. Quality by Design for Pharmaceutical Manufacturing. American Pharmaceutical Review 12(6): 80 – 85.
  17. Hussong, D. 2007. Forward to: Filtration and Purification in the Biopharmaceutical Industry, Second Edition. M. Jornitz and T. Meltzer (eds.). Informa Healthcare, New York, NY.
  18. Hussong, D., and R. Mello. 2006. Alternative microbiological methods and pharmaceutical quality control. American Pharmaceutical Review 9(1): 62, 64 – 68.
  19. Hussong, D. Preface to: Encyclopedia of Rapid Microbiological Methods, Vols. 1 – 3. Michael Miller, editor (2005). Davis Healthcare International, River Grove, IL.
  20. Langille, S., and D. Hussong. 2004. Status and Direction of Aseptic Processing in the United States – 2004. American Pharmaceutical Review. American Pharmaceutical Review 7(6): 28 – 32, 54.
  21. Hussong, D., and R.E. Madsen. 2004. Analysis of Environmental Microbiology Data from Cleanroom Samples. Aseptic Processing 2004, supplement to Pharmaceutical Technology 28: 10 – 14.
  22. Hussong, D. 2003. Environmental monitoring for aseptic processing. American Pharmaceutical Review 6(2): 20 – 24.
  23. Hussong, D., A. Malik, S. Morris, and S.D. Chaparas. 1991. Murine T lymphocyte activation by mycobacterial antigens, In Nuclear and Related Techniques in the Control of Communicable Diseases (July, 1991). International Atomic Energy Agency, Vienna, Austria.
  24. Kadival, G.V., S.D. Chaparas, and D. Hussong. 1991. Specificity of monoclonal antibodies and isolation of serospecific antigen of Mycobacterium tuberculosis. In Nuclear and Related Techniques in the Control of Communicable Diseases (July, 1991). International Atomic Energy Agency, Vienna, Austria.
  25. Morris, S.L., D.A. Rouse, D. Hussong, and S.D. Chaparas. 1990. Isolation and characterization of recombinant lambda gt11 bacteriophages expressing four different Mycobacterium intracellulare antigens. Infection and Immunity 58(1): 17 – 20.
  26. Morris, S.L., D.A. Rouse, D. Hussong, and S.D. Chaparas. 1988. Isolation and characterization of a recombinant lambda gt11 bacteriophage which expresses an immunoreactive Mycobacterium intracellulare protein in Escherichia coli. Infection and Immunity 56(12): 3026 – 3031.
  27. Kadival, G.V., S.D. Chaparas, and D. Hussong. 1987. Characterization of serologic and cell mediated reactivity of a 38 kDa antigen isolated from Mycobacterium tuberculosis. Journal of Immunology 139: 2447 – 2451.
  28. Hussong, D., R.R. Colwell, M. O’Brien, A.D. Pearson, R.M. Weiner, and W.D. Burge. 1987. Viable Legionella pneumophila not detectable by culture on agar media. Bio/Technology 5: 947 – 950.
  29. Burge, W.D., N.K. Enkiri, and D. Hussong. 1987. Salmonella regrowth in compost as influenced by substrate. Microbial Ecology 14: 243 – 253.
  30. Burge, W.D., P.D. Millner, N.K. Enkiri, and D. Hussong. 1987. Regrowth of salmonellae in composted sewage sludge. Water Engineering Research Laboratory, U.S. EPA. EPA/600/S2 86/106.
  31. Westfall, H.N., R.A. Goldwasser, E. Weiss, and D. Hussong. 1986. Prevalence of antibodies to Legionella species in a series of patients in Israel. Israel Journal of Medical Sciences 22: 131 – 138.
  32. Hussong, D., W.D. Burge, and N.K. Enkiri. 1985. Occurrence, growth and suppression of salmonellae in composted sewage sludge. Applied and Environmental Microbiology 50(4): 887 – 893.
  33. Hussong, D., N.K. Enkiri, and W.D. Burge. 1984. Modified agar medium for detecting environmental salmonellae by the most probable number method. Applied Environmental Microbiology 48(5): 1026 – 1030.
  34. Austin, B., D. Hussong, R.M. Weiner, and R.R. Colwell. 1981. Numerical taxonomy analysis of bacteria isolated from the completed `Most Probable Number’ test for coliform bacilli. Journal of Applied Bacteriology 51: 101 – 112.
  35. Hussong, D., R.R. Colwell, and R.M. Weiner. 1981. Seasonal concentration of total coliform bacteria by Crassostrea virginica, the Eastern Oyster in Chesapeake Bay. Journal of Food Protection 44: 201 – 203.
  36. Hussong, D., J.M. Damare, R.R. Colwell, and R.M. Weiner. 1981. Bacteria associated with false positive most probable number test results for shellfish and estuaries. Applied and Environmental Microbiology 41(1): 35 – 45.
  37. Hussong, D., R.R. Colwell, and R.M. Weiner. 1980. Rate of occurrence of false positive results from total coliform MPN analysis of shellfish and estuaries. Applied and Environmental Microbiology 40(5): 981 – 983.
  38. Weiner, R.M., D. Hussong, and R.R. Colwell. 1980. An estuarine agar for the enumeration of heterotrophic bacteria associated with water, sediment and shellfish. Canadian Journal of Microbiology 26(11): 1366 – 1369.
  39. Damare, J.M., D. Hussong, R.M. Weiner, and R.R. Colwell. 1979. Aerobic and facultatively anaerobic bacteria associated with the gut of Canada Geese (Branta canadensis) and Whistling Swans (Cygnus columbianus columbianus ). Applied and Environmental Microbiology 38(2): 258 -266.
  40. Hussong, D., J.M. Damare, R.J. Limpert, R.M. Weiner, W.J.L. Sladen, and R.R. Colwell. 1979. Microbial impact of Canada Geese (Branta canadensis) and Whistling Swans (Cygnus columbianus columbianus) on aquatic ecosystems. Applied and Environmental Microbiology 37(1): 14 – 20.
Invited Presentations
  1. Hussong, D. USP Chapters and Data Interpretation: Activities of the USP Microbiology Expert Committee. Parenteral Drug Association 11th Annual Global Conference on Pharmaceutical Microbiology. 25 – 26 October 2016. Arlington, VA.
  2. Hussong, D. Current and Proposed Future Activities of the USP Microbiology Expert Committee. Parenteral Drug Association 10th Annual Global Conference on Pharmaceutical Microbiology. 19 – 21 October 2015. North Bethesda, MD.
  3. Hussong, D. Myths in Pharmaceutical Manufacturing – Microbiological Myths. Parenteral Drug Association 10th Annual Global Conference on Pharmaceutical Microbiology. 19 – 21 October 2015. North Bethesda, MD.
  4. Hussong, D. Microbiological Risk in Pharmaceutical Products. PDA Metro Chapter Day. 19 May 2015. Somerset, NJ.
  5. Hussong, D. Microbiological Data Deviations. Parenteral Drug Association 9th Annual Global Conference on Pharmaceutical Microbiology. 20 – 22 October 2014. North Bethesda, MD.
  6. Hussong, D. Regulatory Perspective on Testing and Microbiological Risk. USP Workshop on Microbiological Control of Compendial Articles. 18 – 19 March 2013. Rockville, MD.
  7. Hussong, D. Regulatory Review Perspective on USP Chapter <1116>. Parenteral Drug Association Workshop on Understanding Requirements for Cleanrooms. 24 October 2012. Bethesda, MD.
  8. Hussong, D. The Importance of Diverse Scientific Input to Development of Compendial Standards and Regulatory Policy. Pharmaceutical Microbiology Conference on Compendial Issues. 2012. Baltimore, MD.
  9. Hussong, D. Microbiological Examination Test: Absence of specified Microorganism Requirement – A Case for Burkholderia cepacia. Parenteral Drug Association 5th Annual Global Conference on Pharmaceutical Microbiology. 2010. Washington, DC.
  10. Hussong, D. FDA/CDER Perspective on Rapid Microbiological Methods. Parenteral Drug Association 5th Annual Global Conference-Pharmaceutical Microbiology. 2010. Washington, DC.
  11. Hussong, D. Manufacturing Process Controls: CMC and GMP as a Unified Effort for Patient Safety and Effective Therapy. Pharmaceutical Microbiology Forum Conference on Microbial Control. 2010. Key Largo, FL.
  12. Hussong, D. USP Updates on Chapters <1211> Sterilization and Sterility Assurance of Compendial Articles and <1116> Microbiological Control and Monitoring of Aseptic Processing Environments. Open Conference on Compendial Change Summit. Pharmaceutical Microbiology Forum, 2010, Baltimore, MD.
  13. Hussong, D. Product Quality and Regulatory Implications. 7th Annual RMUG Conference. 2009. Philadelphia, PA.
  14. Hussong, D. Rapid Microbiology: Product Quality and Regulatory Implications. United States Pharmacopeia Annual Science Meeting. 2008. Kansas City, MO.
  15. Hussong, D. Rapid Microbiology. United States Pharmacopeia New Science and Technology Advisory Board. 2008. Kansas City, MO.
  16. Lee, A., D. Hussong, K. Brorson and J. McVey. Filter Retention Studies with Hydrogenophaga pseudoflava. PDA/FDA Joint Regulatory Conference. 2008.
  17. Hussong, D. and K. Brorson. Sterility Assurance of Filter Sterilized Pharmaceuticals. FDA Regulatory Science Research Program. 2008. White Oak, MD
  18. Hussong, D. Implementation of Microbiology Internationally Harmonized Microbiology Standards. U.S. Pharmacopeia Prescription/Non-Prescription Stakeholders’ Forum. 2008. Rockville, MD.
  19. Hussong, D. Alternative Microbiology Methods and Pharmaceutical Quality Control. Fifth Annual Rapid Microbiology User’s Group Conference. 2008. San Diego, CA.
  20. Hussong, D. New Drug Microbiology – The Review Challenge. Second Annual Parenteral Drug Association Microbiology Symposium. 2007. Bethesda, MD.
  21. Hussong, D. CDER Review of Sterilization of Combination Products. Radiation Sterilization of Advanced Drug-Device Combination Healthcare Products Conference. 2007. Arlington, VA.
  22. Hussong, D. Rapid Microbiology Data: Criteria and Analysis. Fifth Annual Rapid Microbiology User’s Group Conference. 2007. Arlington, VA.
  23. Hussong, D. USP Chapter <1211> Sterilization and Sterility Assurance of Compendial Articles. 2006 Parenteral Drug Association Microbiology Symposium. 1 November 2006. Bethesda, MD.
  24. Hussong, D. Microbiological Controls in Manufacturing of Sterile and Non-Sterile Products. CDER on CMC: 21st Century Pharmaceutical Manufacturing and Control Strategies – A New Paradigm. University of Rhode Island College of Pharmacy and FDA Joint Conference. 18 October 2006. Reston, VA.
  25. Hussong, D. CMC-Microbiology at CDER: Where are we going? 2006 Pharmaceutical Microbiology Fall Forum. 12 October 2006. Rochester, NY.
  26. Hussong, D. Impacts of ICH Q8, Q9, and Q10 on CMC Microbiology. 2006 PDA/FDA Joint Regulatory Conference. 12 September 2006. Washington, DC.
  27. Hussong, D. Sterile Drug Application Review. In Sterilization and Aseptic Processing for the 21st Century, International Society of Pharmaceutical Engineers 2006 Washington Conference. 7 June 2006. Washington, DC.
  28. Hussong, D. Utilizing Rapid Methods for Compendial Tests, and the Research Exemption. Fourth Annual Rapid Microbiology User’s Group Conference. 26 September 2005. Arlington, VA.
  29. Hussong, D. Laboratory Quality Control, In ASM Workshop WS-02, An introduction to GMP microbiology. American Society for Microbiology. 4 June 2005. New Orleans, LA.
  30. Hussong, D. Case Study: The use of Algorithms in Rapid Microbiology, In Case studies in rapid microbiology methods. 5 April 2005. Parenteral Drug Association 2005 Annual Meeting, Chicago, IL.
  31. Hussong, D., and D. Guilfoyle. What is an Objectionable Organism? In ASM Workshop on Significance and Approach to Objectionable Organisms in a GMP Environment. American Society for Microbiology. 22 May 2004. New Orleans, LA.
  32. Hussong, D. Algorithms: What Are They and What is the Impact of Utilizing Them in Rapid Microbiology. Third Annual Rapid Microbiology User’s Group Conference. 3 May 2004. Rockville, MD.
  33. Hussong, D. Environmental Microbiology Monitoring. Parenteral Drug Association SciTech Summit. 9 March 2004. Orlando, FL.
  34. Hussong, D. Status and direction of aseptic processing in the United States – FDA perspective. American Association of Pharmaceutical Scientists Workshop – Achieving Sterility: Future Direction in Aseptic Processing. 8 December, 2003. Arlington, VA.
  35. Hussong, D. Scientific Review of Sterile Drug Applications at FDA. Italy Chapter of the Parenteral Drug Association. 24 June 2003. Milan, Italy.
  36. Hussong, D. A Brief History of the Rapid (and Slow) Microbial World: A Regulator’s Observations. Rapid Microbiology User’s Group. 14 April 2003. Baltimore, MD.
  37. Hussong, D. Environmental Monitoring of Aseptic Processing. American Association of Pharmaceutical Scientists. 13 November 2002. Toronto, Canada.
  38. Hussong, D. Emerging Global Regulatory Issues: Microbiology Laboratory Issues. Parenteral Drug Association/FDA Joint Regulatory Conference. 11 September 2001. Washington, D.C.
  39. Hussong, D. Drug Application Filing Requirements for Sterilization Process Review: The CDER Perspective. Pharmaceutical Technical Exchange Association. 20 March 2001. Kansas City, MO.
  40. Hussong, D. Current FDA Initiatives – Aseptic Processing, Environmental Monitoring and Aseptic Filling. Parenteral Drug Association European Forum. 6 – 7 November 2000. Basel, Switzerland.
  41. Hussong, D. Environmental Monitoring for Sterile Drug Manufacturing. Delaware Chapter of the Parenteral Drug Association. 20 September 2000. Malvern, PA.
  42. Hussong, D. Microbiology Laboratory Inspection Issues. Parenteral Drug Association/FDA Joint Regulatory Conference. September 11, 2000. Washington, D.C.
  43. Hussong, D., et al. Parenteral Drug Association Special Scientific Forum on Environmental Monitoring. 21 August 2000. Bethesda, MD.
  44. Hussong, D. FDA/CDER Perspectives on Environmental Monitoring. Parenteral Drug Association Annual Meeting Special Forum on Microbiology. 2 December 1999. Washington, D.C.
  45. Hussong, D. Terminal sterilization and Aseptic Processing. Opening presentation to plenary session of Parenteral Drug Association Spring Meeting, AND The Regulatory Perspective on Container and Closure Integrity Testing. 1- 3 March 1999. Orlando,FL.
  46. Hussong, D., and R. Kasubick. Development of Guidance for Post-Approval Changes for Sterile Aqueous Solutions. Panel discussion. NAPM Technical Workshop. National Association of Pharmaceutical Manufacturers. 3 November 1998, Bethesda, MD.
  47. Hussong, D. CDER Development of Guidance for Post-Approval Changes for Sterile Aqueous Solutions. Parenteral Drug Association Spring Meeting. 17 March 1997. San Diego, CA.
  48. Hussong, D., and W. Frieben. Microbiological review of NDAs in the US (panel discussion). Parenteral Drug Association, 4th International Congress. 19 February 1996. Vienna, Austria.
  49. Hussong, D. Process simulation & environmental monitoring for aseptic processing: FDA Reviewer Perspective. PDA Aseptic Processing Forum, Parenteral Drug Association, 7 December 1995. Bethesda, MD.
  50. Hussong, D., and R. Kasubick. Aseptic processing and newer microbiological requirements: Panel discussion. NAPM Fall Technical Workshop. National Association of Pharmaceutical Manufacturers, 19 October 1995. Newark, NJ.
  51. Hussong, D. An FDA review perspective on microbiological evaluation. Annual Meeting of the Parenteral Drug Association. 4 November 1994. Philadelphia, PA.
  52. Hussong, D., and P. Leinbach. Aseptic processing – Drug application filing requirements. Lectures in: International Sterilization Conference. International Cleanroom Control Engineering, 21 23 September 1994. Rome, Italy.
  53. Hussong, D. Alert and action levels from an FDA reviewer’s perspective & other thoughts on environmental control. In Performing environmental sampling and setting alert and action levels. Parenteral Drug Association Special Forum. 14 June 1994. Bethesda, MD.
  54. Hussong, D. New process validation guidelines for injectable dosage forms, In Issues and experiences from new and emerging FDA regulatory initiatives. Sixth International Congress of Pharmaceutical Engineering, 9 11 May 1994. Philadelphia, PA.
  55. Hussong, D. et al. Sterilization process validation: Information to be submitted in human and animal drug applications. FDA Conference and Workshop sponsored jointly by the Center for Drug Evaluation and Research and the Center for Veterinary Medicine, 20 and 21 July 1994. Gaithersburg, MD.
  56. Hussong, D. et al. Sterilization process validation: Information to be submitted in human and animal drug applications. FDA Conference and Workshop sponsored jointly by the Center for Drug Evaluation and Research and the Center for Veterinary Medicine, 8 and 9 February 1994. LaJolla, CA.
  57. Hussong, D., and P. Leinbach. Aseptic processing – Drug application filing requirements. Lectures in: International Sterilization Conference. Belgian Cleanroom Workclub, 6 – 8 December 1993. Brussels, Belgium.
  58. Hussong, D. et al. Sterilization process validation: Information to be submitted in human and animal drug applications. FDA Conference and Workshop sponsored jointly by the Center for Drug Evaluation and Research and the Center for Veterinary Medicine, 1 and 2 June 1993. East Brunswick, NJ.
  59. Hussong, D. et al. Sterilization process validation: Information to be submitted in human and animal drug applications. FDA Conference and Workshop sponsored jointly by the Center for Drug Evaluation and Research and the Center for Veterinary Medicine, 14 and 15 January 1993. Northbrook, IL.
  60. Hussong, D., and P.H. Cooney. A scientific approach to dry heat and steam sterilization theory and validation methods. Lectures in: Industrial Sterilization for Drugs and Devices, a course sponsored by the Office of Regional Operations, FDA, 15 – 16 July 1992. Raleigh, NC.
  61. Hussong, D. 1988. Murine T lymphocyte activation by mycobacterial antigens. First International Seminar Series: (Session I) Nuclear Techniques in Communicable and Parasitic Infections, 21 24 November, 1988. Bombay, India.
  62. Hussong, D. Evidence and detection of non-culturable forms of Legionella species. Seminar Session 295, 86th Annual Meeting, American Society for Microbiology. 1986. Washington, D.C.

 

 

Other Communications
  1. Ahn, Y., J. Kim, K. Wooding, G. Gambos da Costa, J.J. LaPuma, D. Hussong, and C.E. Cerniglia. 2015. Microbial degradation of benzalkonium chloride by Burkholderia cepacia complex. 115th General Meeting, American Society for Microbiology, New Orleans, LA.
  2. Sawant, A., et al. 2014. PDA Technical Report 67. Exclusion of Objectionable Microorganisms from Nonsterile Pharmaceuticals, Medical Devices, and Cosmetics. Parenteral Drug Association, Bethesda, MD.
  3. Ahn, Y., J.M. Kim, H. Ahn, Y-J. Lee, J.J. LiPuma, D. Hussong, and C.E. Cerniglia. 2014. Evaluation of liquid and solid culture media for the recovery and enrichment of Burkholderia cenocepacia from distilled water. 114th General Meeting, American Society for Microbiology, Boston, MA.
  4. Kim, J.M., Y-J Ahn, J.J. LiPuma, D. Hussong, and C. E. Cerniglia. 2014. Investigations into the survival of Burkholderia cepacia complex in chlorohexidine gluconate, benzalkonium chloride and povidone-iodine. 114th General Meeting, American Society for Microbiology, Boston, MA.
  5. Ahn, Y., H. Ahn, Y-J. Lee, J.J. LiPuma, D. Hussong, and C.E. Cerniglia. 2013. A comparison of plating and broth media for the resuscitation and enrichment of Burkholderia cenocepacia in from distilled water. 113th General Meeting, American Society for Microbiology, Denver, CO.
  6. J. Elder, K. J. Jones, A. C. Schuelke, V. M. Echeverria, J. C. Walton, M. J. Sacchetti, P. K. Basu, D. Hussong, Defining Processes to Manufacture Sterile Antiseptics, 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting & Exposition, San Antonio, TX, 10-14 November 2013 (poster W5004).
  7. Raccasi, D., D.E. Guilfoyle, R.L. Friedman, and D. Hussong. 2012. Author Response (to Letter to the Editor) re: “Burkholderia cepacia: This decision is overdue.” PDA Journal of Science and Technology.
  8. Cooney, P.H., D. Hussong, P. Leinbach, C.K. Vincent, and V. Greenman. 1993. Guideline for Submitting Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products. Federal Register 58 (231), pp. 63996 64001, 3 December 1993.
  9. Hussong, D., S.L. Morris, D. Rouse, and S. Chaparas. 1989. Monoclonal antibodies detecting protein antigens of Mycobacterium intracellulare. Session 53, 89th Annual Meeting, American Society for Microbiology, Miami, FL.
  10. Morris, S.L., D. Rouse, D. Hussong, and S. Chaparas. 1989. Isolation and characterization of Mycobacterium intracellulare complex antigens expressed in a lambda gt11 library. Session 256, 89th Annual Meeting, American Society for Microbiology, Miami, FL.
  11. Hussong, D. Radioimmunoassay and dot blot to detect antigens of tuberculous bacilli in cerebrospinal fluid. First International Seminar Series: (Session II) Cooperative Research Programme of Immunodiagnosis of Tuberculosis. 24 – 25 November, 1988, Bombay, India.
  12. Morris, S.R., D. Rouse, D. Hussong, and S.D. Chaparas. 1988. Construction and characterization of a Mycobacterium intracellulare lambda gt11 expression library. Poster U13, 88th Annual Meeting, American Society for Microbiology, St. Louis, MO.
  13. Raoult, D., G.A. Dasch, and D. Hussong. 1987. Lipopolysaccharide cross reactions against Legionella, Proteus, and Rickettsia by sera from patients with Mediterranean spotted fever. Poster E75, 87th Annual Meeting, American Society for Microbiology, Las Vegas, NV.
  14. Colwell, R., A. Pearson, D. Hussong, J. Dennis, J. Lee, J. Byrd, J. Grimes, M. Hood, C. Hutchinson, M. O’Brien, J. Stott, and J. Walker. 1986. Sources, colonization, amplification, and detection of Legionella in cooling towers and water heaters. Poster B6 10, XIV International Congress of Microbiology, International Union of Microbiological Societies, Manchester, England.
  15. Westfall, H.N., R.A. Goldwasser, D. Hussong, G.A. Dasch, and E. Weiss. 1986. Serological evidence that Legionella bozemanii and Rickettsia typhi share cross reacting antigens. Poster C409, 86th Annual Meeting, American Society for Microbiology, Washington, D.C.
  16. Hussong, D., W.D. Burge, and N.K. Enkiri. 1984. Growth and death of salmonellae in composted sewage sludge. Poster Q93, 84th Annual Meeting, American Society for Microbiology, St. Louis, MO.
  17. Burge, W.D., N.K. Enkiri, and D. Hussong. 1984. Quantitation of substrate capable of supporting salmonellae regrowth in sewage sludge compost. Poster Q53, 84th Annual Meeting, American Society for Microbiology, St. Louis, MO.
  18. Hussong, D., and R.M. Weiner. 1977. Density of fecal indicator bacteria in Rhode and South River estuaries of the Chesapeake Bay. Technical Report 127, Chesapeake Research Consortium.

 

Verified by MonsterInsights

Terms and Conditions - Privacy Policy